etomidate has been researched along with Morbid Obesity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaszynski, TM; Jakubiak, J; Szewczyk, T | 1 |
| Bałkota, M; Bejm, J; Możański, M; Rybicki, Z; Tomaszewski, D | 1 |
| Amado, JA; Del Moral, I; García-Unzueta, MT; Montalbán, C; Villanueva, MA | 1 |
2 trial(s) available for etomidate and Morbid Obesity
| Article | Year |
|---|---|
Etomidate, but not thiopental, decreases serum cortisol concentration in morbidly obese patients. A randomized controlled trial.
Topics: Adult; Anesthetics, Intravenous; Etomidate; Hemodynamics; Humans; Hydrocortisone; Middle Aged; Obesity, Morbid; Thiopental | 2016 |
Perioperative response of leptin and the tumor necrosis factor alpha system in morbidly obese patients. Influence of cortisol inhibition by etomidate.
Topics: Adrenocorticotropic Hormone; Adult; Anesthetics, Intravenous; Etomidate; Female; Gastroplasty; Humans; Hydrocortisone; Laparotomy; Leptin; Middle Aged; Obesity, Morbid; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Time Factors; Tumor Necrosis Factor-alpha | 2001 |
1 other study(ies) available for etomidate and Morbid Obesity
| Article | Year |
|---|---|
Etomidate can be dosed according to ideal body weight in morbidly obese patients.
Topics: Adult; Anesthetics, Intravenous; Etomidate; Female; Humans; Ideal Body Weight; Male; Middle Aged; Obesity, Morbid | 2014 |